189 related articles for article (PubMed ID: 25815071)
1. Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin.
Ünal H; Öztürk N; Bilensoy E
Beilstein J Org Chem; 2015; 11():204-12. PubMed ID: 25815071
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
Ünal S; Aktaş Y; Benito JM; Bilensoy E
Int J Pharm; 2020 Jun; 584():119468. PubMed ID: 32470483
[TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
5. Multilayered polymer coating modulates mucoadhesive and biological properties of camptothecin-loaded lipid nanocapsules.
Isadora Boni F; Noronha Ferreira N; Fernanda Rodero C; Franciane Leão A; Stringhetti Ferreira Cury B; Palmira Daflon Gremião M
Int J Pharm; 2023 Mar; 635():122792. PubMed ID: 36863543
[TBL] [Abstract][Full Text] [Related]
6. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.
Varan G; Benito JM; Mellet CO; Bilensoy E
Beilstein J Nanotechnol; 2017; 8():1457-1468. PubMed ID: 28900599
[No Abstract] [Full Text] [Related]
7. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
Ünal S; Can Öztürk S; Bilgiç E; Yanık H; Korkusuz P; Aktaş Y; Benito JM; Esendağlı G; Bilensoy E
Eur J Pharm Biopharm; 2021 Dec; 169():168-177. PubMed ID: 34700001
[TBL] [Abstract][Full Text] [Related]
8. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
He W; Du Y; Zhou W; Wang T; Li M; Li X
Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations.
Real D; Hoffmann S; Leonardi D; Salomon C; Goycoolea FM
PLoS One; 2018; 13(12):e0207625. PubMed ID: 30540811
[TBL] [Abstract][Full Text] [Related]
10. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
11. Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.
Niu Z; Tedesco E; Benetti F; Mabondzo A; Montagner IM; Marigo I; Gonzalez-Touceda D; Tovar S; Diéguez C; Santander-Ortega MJ; Alonso MJ
J Control Release; 2017 Oct; 263():4-17. PubMed ID: 28235590
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
Roger E; Lagarce F; Benoit JP
Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive drug carrier based on functional-modified cellulose as poorly water-soluble drug delivery system.
Songsurang K; Siraleartmukul K; Muangsin N
J Microencapsul; 2015; 32(5):450-9. PubMed ID: 26052720
[TBL] [Abstract][Full Text] [Related]
14. CPT loaded nanoparticles based on beta-cyclodextrin-grafted poly(ethylene glycol)/poly (L-glutamic acid) diblock copolymer and their inclusion complexes with CPT.
Du F; Meng H; Xu K; Xu Y; Luo P; Luo Y; Lu W; Huang J; Liu S; Yu J
Colloids Surf B Biointerfaces; 2014 Jan; 113():230-6. PubMed ID: 24096159
[TBL] [Abstract][Full Text] [Related]
15. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
16. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery.
Du Y; Ling L; Ismail M; He W; Xia Q; Zhou W; Yao C; Li X
Int J Pharm; 2018 Oct; 549(1-2):352-362. PubMed ID: 30099214
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent.
Kang J; Kumar V; Yang D; Chowdhury PR; Hohl RJ
Eur J Pharm Sci; 2002 Mar; 15(2):163-70. PubMed ID: 11849913
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
19. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery.
Meng L; Huang W; Wang D; Huang X; Zhu X; Yan D
Biomacromolecules; 2013 Aug; 14(8):2601-10. PubMed ID: 23819825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
